HOLLISTON, Mass., Jan. 8, 2014 /PRNewswire/ -- Humans have always organized things. Something in our brains tells us to break information into smaller chunks, making it easier to understand. We separate animals into different species, books into genres and clothing into styles. In this era of endless medical specialization, our aptitude for grouping is more important than ever. For each specialty area, there are thousands of pieces of equipment: it seems as though there's a new device on the market every day. So how can doctors and medical research groups find the research apparatus and products needed to complete their projects?
Enter Harvard Bioscience, a global developer that manufactures and markets a broad range of specialized products. Their primary focus is on the scientific instruments used to advance life science and research. In 1901, the highly respected William T. Porter founded the company while teaching at Harvard Medical School. Dr. Porter became frustrated by the poor quality of equipment available to him, so he took matters into his own hands: he began manufacturing his own high-quality teaching equipment in the basement at Harvard. This equipment gained an enviable reputation for quality and reliability. As a result, Dr. Porter's business took off and eventually became the giant it is today.
Harvard Bioscience has become one of the leading worldwide suppliers of scientific instruments specifically used to improve life science research. Their products are sought after for both well-established and cutting-edge applications, and are being used by some of the world's top pharmaceutical and biotech companies and universities. Their products are typically highly specialized for particular research applications in molecular, cellular and physiological research.
"Our brands are popular names that convey quality and consistency," said Jeffrey A.
SOURCE Harvard Bioscience
Copyright©2012 PR Newswire.
All rights reserved
Related medicine technology :
1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
8. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
11. Okuma America Chooses The Daniel Group To Provide Customer Service Research